We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Minimally Invasive Surgical Technique Limits Blood Loss by Partially Blocking Aorta

By HospiMedica International staff writers
Posted on 02 Oct 2023

Hemorrhagic shock, a condition where severe blood loss compromises the body's ability to supply oxygen to its cells, is the main cause of death after traumatic injuries. More...

Specifically, treating injuries to non-compressible areas like the torso and abdomen presents a difficult clinical problem, as there are limited ways to control bleeding without further injuring the body. Some trauma centers globally employ Endovascular Hemorrhage Control (EHC) devices and minimally invasive methods. Among these is the partial resuscitative endovascular balloon occlusion of the aorta (REBOA), a technique involving the placement of a balloon in the aorta to limit blood flow beneath the heart and control severe bleeding. Now, a team of acute care surgeons is planning a study to evaluate the effectiveness and safety of using REBOA for hemorrhage control.

Acute care surgeons at Vanderbilt University Medical Center (Nashville, TN, USA) are leading a two-year, multicenter observational study on REBOA. This procedure involves feeding a small catheter equipped with a balloon through the femoral artery, and positioning it within the aorta— the body's largest artery. When inflated, the balloon restricts the blood flow below the aorta and helps stabilize blood pressure, allowing life to be sustained while addressing the root cause of the bleeding. REBOA received FDA approval in 2017, and the latest version of this device allows for controlling partial blood flow to the rest of the body. This is anticipated to minimize risk and provide medical teams with additional time to surgically halt the bleeding.

Although REBOA has been shown to be effective in controlling blood loss, it comes with some risks. Limiting blood flow for extended periods can lead to ischemia-reperfusion injuries or tissue damage that occurs when blood supply is restored to the tissue. The most frequent complication arising from REBOA is acute kidney injury (AKI) which can affect as many as 40% of individuals who survive hemorrhagic shock and undergo REBOA treatment.

“We believe from our experience with the device that it clearly has benefits, but we want to fine-tune this procedure so we can provide the maximum benefit for the greatest number of patients,” said co-principal investigator Bradley Dennis, MD, associate professor of Surgery and medical director of VUMC’s Trauma Intensive Care Unit. “Doing this now, in a controlled fashion with a limited number of trauma centers, will help us standardize partial REBOA use and identify the best practices so we can then help spread that information to the rest of the country.”

Related Links:
Vanderbilt University Medical Center


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Pediatric Cast Saw
CSP-201 Quietcast
New
Warming Cabinet
EC1850BL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new AI-based method can predict treatment outcomes from health record data (Photo courtesy of 123RF)

AI Tool Accurately Sorts Cancer Patients by Likely Outcomes

Pharmaceutical companies and healthcare providers often face the challenge of determining which patients will respond most effectively to a given drug. A new artificial intelligence (AI)-based method has... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.